In a 27-year-old nulligravida with infertility, heavy menstrual bleeding and dysmenorrhea partially relieved by ibuprofen, what is the pathophysiologic contributor of endometriosis to menorrhagia and dysmenorrhea, and what is the initial diagnostic study (laparoscopy, MRI, CT, or transvaginal ultrasound)?

Initial Diagnostic Study for Suspected Endometriosis

Transvaginal ultrasound is the initial imaging study of choice for this 27-year-old woman with suspected endometriosis presenting with infertility, dysmenorrhea, and heavy menstrual bleeding 1.

Pathophysiologic Mechanisms

Endometriosis contributes to menorrhagia and dysmenorrhea through several interconnected mechanisms:

• Inflammation and prostaglandin production: Ectopic endometrial-like tissue outside the uterine cavity triggers chronic inflammation and increased prostaglandin synthesis, which intensifies uterine contractions and pain 1, 2
• Nociception and central sensitization: Pain results from direct nerve involvement, hyperalgesia, and central nervous system sensitization that amplifies pain signals 3
• Anatomic distortion: Lesions on the uterosacral ligaments, posterior vaginal fornix, and other pelvic structures cause mechanical pain, particularly with menstruation 3

The dysmenorrhea this patient experiences with partial relief from ibuprofen is consistent with prostaglandin-mediated pain, as NSAIDs inhibit prostaglandin synthesis 4, 2.

Diagnostic Algorithm

First-Line Imaging: Transvaginal Ultrasound

Transvaginal ultrasound should be performed first because:

• It accurately detects ovarian endometriomas with high sensitivity 1
• It is non-invasive, widely available, and involves no radiation exposure 1
• When combined with transabdominal ultrasound, it can evaluate the urinary tract and bowel for deep infiltrating endometriosis 1
• Recent 2024 ACR guidelines support preoperative imaging to reduce surgical morbidity and prevent incomplete surgeries 1

Important caveat: Standard transvaginal ultrasound may miss deep infiltrating endometriosis. Expanded protocol TVUS (performed by specialists with specific training) has significantly higher sensitivity but is not widely available in the United States 1.

Second-Line Imaging: MRI Pelvis

MRI pelvis (with or without IV contrast) should be considered if:

• Transvaginal ultrasound is negative but clinical suspicion remains high
• Deep infiltrating endometriosis is suspected based on symptoms (dyschezia, dysuria)
• Surgical planning is needed 1

MRI provides excellent detection of deep endometriosis and offers a larger field of view than ultrasound 1. The 2024 ACR guidelines note that IV contrast helps differentiate endometriomas from ovarian malignancies, though one study found no benefit of contrast specifically for detecting deep endometriosis 1.

When to Proceed to Laparoscopy

Diagnostic laparoscopy should be reserved for:

• Negative imaging with persistent symptoms
• Failed empirical hormonal treatment
• When definitive histologic diagnosis is required
• Surgical treatment is planned 1

Historically, laparoscopy was the gold standard for diagnosis, but current evidence supports imaging-first approaches to reduce surgical morbidity 1.

What NOT to Order

CT pelvis (with or without contrast) has no role in initial endometriosis evaluation—there is no supporting literature for its use 1.

Clinical Pitfalls to Avoid

• Normal imaging does not exclude endometriosis: Superficial peritoneal disease is poorly detected by both ultrasound and MRI 1
• Symptom severity does not correlate with disease extent: Minimal endometriosis can cause severe pain, while extensive disease may be asymptomatic 1, 2
• Don't delay empirical treatment: If imaging is unavailable or negative but clinical suspicion is high, hormonal suppression can be initiated while awaiting specialist referral 5, 6
• Consider infertility impact: Approximately 50% of women with endometriosis experience infertility 1. This patient's nulligravida status and inability to conceive warrant concurrent fertility evaluation

Management Context

While addressing the diagnostic question, note that combined oral contraceptives or progestin-only medications are first-line treatment for symptomatic premenopausal women not currently seeking pregnancy 7. These reduce pain by 13-17 points on a 100-point visual analog scale compared to placebo 7. However, 11-19% have no response, and 25-34% experience recurrent pain within 12 months of discontinuation 7.

The patient's partial response to ibuprofen (400 mg every 4-6 hours for dysmenorrhea per FDA labeling 4) suggests prostaglandin-mediated pain but does not provide adequate symptom control, warranting hormonal therapy consideration alongside diagnostic workup.